Stockscreener 앱 받기
4.77
8.27%
-0.43
시장 영업 전:
4.68
-0.09
-1.89%
전일 마감가:
$5.20
열려 있는:
$5.12
하루 거래량:
1.26M
Relative Volume:
0.14
시가총액:
$27.15M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.3753
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
-3.83%
1개월 성능:
+284.68%
6개월 성능:
+228.97%
1년 성능:
+67.37%
1일 변동 폭
$4.54
$5.23
1주일 범위
$4.54
$7.25
52주 변동 폭
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
명칭
Tharimmune Inc
전화
302-743-2995
주소
1200 ROUTE 22 EAST, BRIDGEWATER
THAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
4.77 | 27.75M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tharimmune Inc 주식(THAR)의 최신 뉴스
Visual trend scoring systems applied to Tharimmune Inc.Chart Signals & Safe Entry Point Alerts - Newser
Is Tharimmune Inc. meeting your algorithmic filter criteriaBond Market & Long-Term Safe Investment Plans - Newser
Custom strategy builders for tracking Tharimmune Inc.Weekly Investment Summary & Expert Approved Trade Ideas - Newser
These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025 - The Motley Fool
Will a bounce in Tharimmune Inc. offer an exitWeekly Market Report & Community Consensus Picks - Newser
Is Tharimmune Inc. stock ready for a breakoutPortfolio Performance Report & Accurate Buy Signal Alerts - Newser
Will Tharimmune Inc. bounce back from current supportWeekly Risk Report & Growth-Oriented Investment Plans - Newser
Is Tharimmune Inc. a candidate for recovery playJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - Newser
Sentiment analysis tools applied to Tharimmune Inc.M&A Rumor & Fast Entry High Yield Stock Tips - Newser
Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants - Pocono Record
Risk adjusted return profile for Tharimmune Inc. analyzedJuly 2025 Technicals & Community Supported Trade Ideas - Newser
How hedge fund analytics apply to Tharimmune Inc. stock2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser
Using flow based indicators on Tharimmune Inc.July 2025 Action & Fast Momentum Stock Entry Tips - Newser
What technical models suggest about Tharimmune Inc.’s comebackJuly 2025 Highlights & Capital Protection Trade Alerts - Newser
What recovery options are there for Tharimmune Inc.IPO Watch & Advanced Swing Trade Entry Plans - Newser
Does Tharimmune Inc. show high probability of reboundWeekly Profit Analysis & Expert Curated Trade Setup Alerts - Newser
Is Tharimmune Inc. showing insider buying2025 Performance Recap & Smart Investment Allocation Tips - khodrobank.com
RSI Divergence May Trigger a Bounce in Tharimmune Inc.July 2025 Movers & Technical Confirmation Alerts - beatles.ru
Detecting support and resistance levels for Tharimmune Inc.2025 Trade Ideas & Technical Confirmation Trade Alerts - Newser
Has Tharimmune Inc. formed a bullish divergenceEntry Point & Free Community Consensus Stock Picks - Newser
What MACD signals say about Tharimmune Inc.Weekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Using data filters to optimize entry into Tharimmune Inc.2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
Top chart patterns to watch in Tharimmune Inc.Quarterly Trade Report & Expert Approved Momentum Ideas - Newser
Visual analytics tools that track Tharimmune Inc. performanceWeekly Stock Report & Low Drawdown Investment Strategies - Newser
Identifying reversal signals in Tharimmune Inc.Market Sentiment Summary & AI Based Trade Execution Alerts - Newser
How to build a dashboard for Tharimmune Inc. stockCEO Change & Growth Oriented Trading Recommendations - Newser
Chart overlay techniques for tracking Tharimmune Inc.2025 Market WrapUp & AI Based Buy and Sell Signals - Newser
Is Tharimmune Inc. Starting a New Uptrend getLinesFromResByArray error: size == 0 - newsyoung.net
Tharimmune Inc (THAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
1.34%
자본화:
|
볼륨(24시간):